Alnylam Chief Commercialization Officer Tolga Tanguler to Depart in December 2026
- Alnylam Pharmaceuticals announced November 4, 2026, that Executive Vice President, Chief Commercialization Officer Tolga Tanguler will depart in December 2026.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alnylam Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001178670-26-000080), on November 05, 2026, and is solely responsible for the information contained therein.